advertisement
Pillunat LE 8
Showing records 1 to 8 | Display all abstracts from Pillunat LE73349 Preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% in patients with open-angle glaucoma and ocular hypertension: results of an open-label observational study
Pillunat LE
Clinical Ophthalmology 2017; 11: 1051-1064
73181 Assessment of Optic Nerve Head Pallor in Primary Open-Angle Glaucoma Patients and Healthy Subjects
Ramm L; Schwab B
Current Eye Research 2017; 0: 1-6
73349 Preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% in patients with open-angle glaucoma and ocular hypertension: results of an open-label observational study
Erb C
Clinical Ophthalmology 2017; 11: 1051-1064
73181 Assessment of Optic Nerve Head Pallor in Primary Open-Angle Glaucoma Patients and Healthy Subjects
Stodtmeister R
Current Eye Research 2017; 0: 1-6
73349 Preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% in patients with open-angle glaucoma and ocular hypertension: results of an open-label observational study
Ropo A; Kimmich F
Clinical Ophthalmology 2017; 11: 1051-1064
73181 Assessment of Optic Nerve Head Pallor in Primary Open-Angle Glaucoma Patients and Healthy Subjects
Hammer M
Current Eye Research 2017; 0: 1-6
73349 Preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% in patients with open-angle glaucoma and ocular hypertension: results of an open-label observational study
Pfeiffer N
Clinical Ophthalmology 2017; 11: 1051-1064
73181 Assessment of Optic Nerve Head Pallor in Primary Open-Angle Glaucoma Patients and Healthy Subjects
Sauer L; Spörl E; Pillunat LE; Terai N
Current Eye Research 2017; 0: 1-6
